| Whitestar Wellness Sc | |
|
4685 Pilgrim Rd Brookfield WI 53005-1556 | |
| (414) 630-2743 | |
| Not Available |
| Full Name | Whitestar Wellness Sc |
|---|---|
| Speciality | Clinic/Center |
| Location | 4685 Pilgrim Rd, Brookfield, Wisconsin |
| Authorized Official Name and Position | Ariel Namowicz (OWNER) |
| Authorized Official Contact | 2743414630 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Whitestar Wellness Sc 4685 Pilgrim Rd Brookfield WI 53005-1556 Ph: () - | Whitestar Wellness Sc 4685 Pilgrim Rd Brookfield WI 53005-1556 Ph: (414) 630-2743 |
| NPI Number | 1205566353 |
|---|---|
| Provider Enumeration Date | 06/13/2022 |
| Last Update Date | 09/13/2022 |
| Certification Date | 08/30/2022 |
| Medicare PECOS PAC ID | 1355725102 |
|---|---|
| Medicare Enrollment ID | O20220829002577 |
News Archive
Mobile phone use during pregnancy is unlikely to have any adverse effects on child neurodevelopment, according to new research published in the open access journal BMC Public Health.
An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) notified the companies that it will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC).
An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer.
Studies reporting on the effectiveness of new therapies for chronic Hepatitis C virus are among the clinical science presented at the American College of Gastroenterology's 76th Annual Scientific Meeting, where investigators also presented findings from an age-based risk assessment and screening intervention for Hepatitis C among Baby Boomers, patients aged 50-65, who saw a gastroenterologist for routine colon cancer screening.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205566353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 104100000X | Social Worker | (* (Not Available)) | Secondary |
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Ariel Marie Namowicz |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1164068565 PECOS PAC ID: 2264816016 Enrollment ID: I20221112000106 |
News Archive
Mobile phone use during pregnancy is unlikely to have any adverse effects on child neurodevelopment, according to new research published in the open access journal BMC Public Health.
An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) notified the companies that it will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC).
An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer.
Studies reporting on the effectiveness of new therapies for chronic Hepatitis C virus are among the clinical science presented at the American College of Gastroenterology's 76th Annual Scientific Meeting, where investigators also presented findings from an age-based risk assessment and screening intervention for Hepatitis C among Baby Boomers, patients aged 50-65, who saw a gastroenterologist for routine colon cancer screening.
› Verified 5 days ago
News Archive
Mobile phone use during pregnancy is unlikely to have any adverse effects on child neurodevelopment, according to new research published in the open access journal BMC Public Health.
An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) notified the companies that it will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for linaclotide for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC).
An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ovarian cancer.
Studies reporting on the effectiveness of new therapies for chronic Hepatitis C virus are among the clinical science presented at the American College of Gastroenterology's 76th Annual Scientific Meeting, where investigators also presented findings from an age-based risk assessment and screening intervention for Hepatitis C among Baby Boomers, patients aged 50-65, who saw a gastroenterologist for routine colon cancer screening.
› Verified 5 days ago
Christian Life Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12630 W North Ave Bldg E, Brookfield, WI 53005 Phone: 262-785-1008 Fax: 262-432-9059 | |
Lifestance Health Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 16535 W Bluemound Rd, Suite 200, Brookfield, WI 53005 Phone: 262-789-1191 Fax: 262-821-6180 | |
Dbt Consultants Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 S. Executive Drive, Ste. 101, Brookfield, WI 53005 Phone: 414-305-6588 | |
The Anxiety Center Acquisition, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15850 W Bluemound Rd Ste 208, Brookfield, WI 53005 Phone: 262-719-5898 Fax: 262-641-9040 | |
Trueblood Psychological Services, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 19275 W Capitol Dr Ste 200, Brookfield, WI 53045 Phone: 262-222-2882 Fax: 414-431-6018 | |
Gorecki Psychological Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 19275 W Capitol Dr Ste 200, Brookfield, WI 53045 Phone: 262-546-7478 Fax: 262-373-0362 | |
Tgl Wellness Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1750 N Calhoun Rd, Brookfield, WI 53005 Phone: 414-218-6958 |